Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs): Is there consensus?

Keyphrases

• Laboratory Assessment 100%
• Direct Oral Anticoagulants 100%
• Dabigatran 75%
• Apixaban 75%
• Rivaroxaban 75%
• Anti-FXa 75%
• Drug Effects 50%
• Activated Partial Thromboplastin Time (aPTT) 50%
• Screening Assays 50%
• Prothrombin Time 50%
• Quantitative Assay 50%
• Anti-FXa Assay 50%
• Ecarin 50%
• Recommended Screening 50%
• Laboratory Monitoring 25%
• Clot 25%
• Guideline Recommendations 25%
• Dogma 25%
• Thrombin 25%
• Laboratory Testing 25%
• Direct Inhibitors 25%
• Low Quality Data 25%
• Effect Level 25%
• Inhibition Assay 25%
• Thrombin Time 25%
• Factor IIa 25%
• Activated Factor X 25%
• Edoxaban 25%
• Factor Xa Inhibitors 25%
• Antithrombotic Agents 25%
• Direct Thrombin Inhibitors 25%
• Dilute Thrombin Time 25%
• Hemoclot Thrombin Inhibitor Assay 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Direct Oral Anticoagulant 100%
• Thrombin 75%
• Rivaroxaban 75%
• Apixaban 75%
• Dabigatran 75%
• Prothrombin 50%
• Thrombin Inhibitor 50%
• Ecarin 50%
• Thromboplastin 50%
• Anticoagulant Agent 25%
• Blood Clotting Factor 10 25%
• Edoxaban 25%